Should You Buy These Stocks? Experts Weigh In on Consumer Goods, Healthcare, and Chemicals

India's Economic Rise: Which Stocks Are the Experts Betting On? Discover Top Picks for Potential Gains in Consumer Staples, Healthcare, and Chemicals

India's outperforming economy is attracting the attention of both domestic and international brokerages. As a result, several experts are recommending investments in promising companies, expecting continued market growth.

What stocks are being recommended?

Shares... Let's buy...
Shares... Let's buy...

Honanza Consumer Limited, Abhijay Surrendra Park Hotels Limited, Yatharth Hospitals & Trauma Care Service Limited, and Archean Chemical Industries Limited are some of the companies recommended by various brokerages, both international and domestic.

These companies are seen as potential buys with the possibility of up to 38% growth. The recommendation comes at a time when the market is already experiencing a strong upswing.

Honanza Consumer Limited (Target Price: Rs 550, Potential Gain: 26%):

Honanza, a leading FMCG company, has been lauded by Citi for its consistent product innovation, strong distribution network, and brand building efforts.

Honanza Consumer - Stock Recommendation
Honanza Consumer - Stock Recommendationstocks to buy

These factors, coupled with the rising demand in India, are expected to drive significant long-term growth.

Bramayugam Review: A technically sound film powered by Mammootty's menacing screen presence!

Apeejay Surrendra Park Hotels Ltd (Target Price: Rs 285, Potential Gain: 30%):

Apeejay Surendra Park Hotels
- Stocks Referral
Apeejay Surendra Park Hotels - Stocks Referral

Ananda Rathi recommends Apeejay Surrendra, a prominent player in the luxury hotel segment. The company operates across various segments, offering luxurious accommodations in key commercial locations. Apeejay Surrendra Park Hotels' competitive pricing strategy and focus on customer satisfaction have consistently fueled its growth. However, the brokerage firm cautions that potential economic pressure could impact hotel revenue.

Yatharth Hospitals & Trauma Care Services Ltd (Target Price: Rs 658, Potential Gain: 38%)

SMIFS recommends Yatharth Hospitals, a leading healthcare provider with significant expansion plans. The company aims to double its bed capacity to 2,810 within the next five years.

Its focus on major cities, diverse treatment options, and technological advancements are seen as potential growth drivers. The brokerage firm expects these factors to improve the company's margins and recommends buying the stock.

Yatharth Hospitals & Drama Care - Stocks Recommendation
Yatharth Hospitals & Drama Care - Stocks Recommendation

Archean Chemicals Industries Ltd (Target Price: Rs 658, Potential Gain: 5%):

BP Equities recommends Archean Chemicals, a diversified chemical company with a strong international presence. The company's diverse product portfolio, international clientele, and projected revenue and profit growth make it an attractive investment option.

Archeon Chemicals- Stock Recommendation
Archeon Chemicals- Stock Recommendation

This article is for informational purposes only and should not be considered financial advice. Please consult with a qualified financial advisor before making any investment decisions.

Data in this section is not a buy/sell recommendation but only a compilation of information on various technical/volume-based parameters

Analyst certifies that all of the views, if any, expressed in this report reflect his personal views about the subject company or companies and its or their securities, and no part of his compensation was, is or will be, directly or indirectly related to specific recommendations or views expressed in this report. Analyst affirms that there exists no conflict of interest that can bias his views in this report. The Analyst does not hold any share(s) in the company/ies discussed.

General Disclaimer and Terms & Conditions of the research report

INVESTMENT IN SECURITIES MARKET ARE SUBJECT TO MARKET RISKS. READ ALL THE RELATED DOCUMENTS CAREFULLY BEFORE INVESTING. Registration granted by SEBI and certification from NISM in no way guarantee performance of the intermediary or provide any assurance of returns to investors. For a detailed disclaimer and disclosure please visit Before making an investment/trading decision on the basis of this data you need to consider, with the assistance of a qualified adviser, whether the investment/trading is appropriate in light of your particular investment/trading needs, objectives and financial circumstances.

One year Price history of the daily closing price of the securities covered in this section is available at (Choose the respective symbol) /name of company/time duration)

Investments should be done only after consulting a SEBI registered  investment     advisor. It can be profitable to wait for the right opportunities and buy fewer  when those opportunities are available.  

This Article was originally written by S Pugazharasi and appeared in Here is the revised english version.


No stories found.
Vikatan English